Participant‐reported pain relief of 50% or greater · adults with postherpetic neuralgia
1 finding from 1 review
Withdrawals due to adverse events · adults with neuropathic pain
1 finding from 1 review
Serious adverse events · adults with neuropathic pain
1 finding from 1 review
Death · adults with neuropathic pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
IMMPACT definition ‐ any substantial pain benefit · adults with postherpetic neuralgia
1 finding from 1 review
Patient Global Impression of Change much or very much improved · adults with postherpetic neuralgia
1 finding from 1 review
IMMPACT definition ‐ any at least moderate pain benefit · adults with postherpetic neuralgia
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · people with diabetic peripheral neuropathy
1 finding from 1 review
'Substantial benefit' (≥ 50% reduction in pain or PGIC very much improved) · people with diabetic peripheral neuropathy
1 finding from 1 review
Patient Global Impression of Change much or very much improved · people with diabetic peripheral neuropathy
1 finding from 1 review
Moderate benefit: At least 30% reduction in pain, or PGIC much or very much improved · people with diabetic peripheral neuropathy
1 finding from 1 review
Proportion of participants experiencing adverse events · adults with neuropathic pain
1 finding from 1 review
At least 30% reduction in pain · adults with fibromyalgia
1 finding from 1 review
At least 50% reduction in pain · adults with fibromyalgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
PGIC ‐ any category of "better" at 12 weeks · adults with fibromyalgia
1 finding from 1 review
Withdrawals due to adverse events · adults with fibromyalgia
1 finding from 1 review
Serious adverse events · adults with fibromyalgia
1 finding from 1 review
Deaths · adults with fibromyalgia
1 finding from 1 review